Loading...
•
Jun 30
Ingersoll Rand Q2 2025 Earnings Report
Ingersoll Rand reported record second quarter orders, revenue, and adjusted EBITDA, driven by strong performance and strategic acquisitions.
Key Takeaways
Ingersoll Rand delivered a strong second quarter in 2025, achieving record orders, revenue, and adjusted EBITDA. The company reported an 8% increase in orders to $1,940 million and a 5% rise in revenues to $1,888 million. Despite a reported net loss of $115 million due to non-cash impairments, adjusted net income stood at $325 million, with adjusted EBITDA reaching $509 million, up 3%. The company maintained a strong financial position with $3.9 billion in liquidity and continued its capital allocation strategy through M&A and shareholder returns.
Record second quarter orders of $1,940 million, an 8% increase year-over-year.
Record revenues of $1,888 million, up 5% compared to the second quarter of 2024.
Adjusted EBITDA reached $509 million, a 3% increase, with an adjusted EBITDA margin of 27.0%.
Reported a net loss of $115 million ($0.29 per share) due to non-cash impairments, but adjusted net income was $325 million ($0.80 per share).
Ingersoll Rand
Ingersoll Rand
Ingersoll Rand Revenue by Segment
Revenue by Segment
Industrial Technologies & Services Revenue
CapyFin.comPrecision & Science Technologies Revenue
CapyFin.com Forward Guidance
Ingersoll Rand is raising its full-year 2025 guidance for Revenue, Adjusted EBITDA, and Adjusted EPS, reflecting confidence in continued growth.
Positive Outlook
- Total Ingersoll Rand revenue growth projected at 4-6%.
- Adjusted EBITDA expected to be between $2,100 million and $2,160 million, representing a 4-7% year-over-year increase.
- Adjusted EPS projected to be between $3.34 and $3.46, indicating a 2-5% year-over-year growth.
- Anticipated M&A contribution of approximately $375 million to revenue.
- Positive FX impact of approximately 1% on revenue.
Challenges Ahead
- Organic revenue for Total Ingersoll Rand projected to decline by 0-2%.
- Industrial Technologies & Services organic revenue projected to decline by 0-2%.
- Precision & Science Technologies organic revenue projected to decline by 0-2%.
- Corporate costs are expected to be approximately $160 million.
- Reconciliations of non-GAAP measures for full-year guidance are not provided due to high variability and complexity, which could have an unpredictable and significant impact on future GAAP financial results.
Revenue & Expenses
Visualization of income flow from segment revenue to net income